ÂÜÀòÂÒÂ×

Steve has been in the pharmaceutical industry for over 25 years. He currently is the Vice President of Research and Development at Promentis Pharmaceuticals, Inc., an early-stage pharmaceutical development group focusing on creating new treatments for schizophrenia and other neurological disorders. Steve earned a BS in Pharmacy from the University of Wisconsin, and is a licensed Pharmacist. His MBA was awarded by Western Michigan University.